home / stock / murf / murf quote
Last: | $16.85 |
---|---|
Change Percent: | 5.83% |
Open: | $16 |
Close: | $16.85 |
High: | $18.3 |
Low: | $11.0401 |
Volume: | 228,000 |
Last Trade Date Time: | 09/22/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$16.85 | $16 | $16.85 | $18.3 | $11.0401 | 228,000 | 09-22-2023 |
$16.99 | $19.99 | $16.99 | $22 | $16.09 | 1,102,582 | 09-21-2023 |
$12.84 | $12 | $12.84 | $16.4528 | $12 | 237,200 | 09-20-2023 |
$14.1 | $11.07 | $14.1 | $25 | $11.03 | 503,498 | 09-19-2023 |
$11.3 | $10 | $11.3 | $11.42 | $9.8 | 58,752 | 09-18-2023 |
$10.24 | $10.88 | $10.24 | $10.88 | $10.04 | 31,718 | 09-15-2023 |
$10.89 | $10.89 | $10.89 | $10.9 | $10.89 | 3,206 | 09-14-2023 |
$10.82 | $10.82 | $10.82 | $10.82 | $10.8 | 1,506 | 09-13-2023 |
$10.82 | $0 | $10.82 | $0 | $0 | 123 | 09-12-2023 |
$10.82 | $10.78 | $10.82 | $10.83 | $10.7799 | 1,868 | 09-11-2023 |
$10.78 | $10.75 | $10.78 | $10.78 | $10.7494 | 4,345 | 09-08-2023 |
$10.78 | $10.74 | $10.78 | $10.78 | $10.74 | 3,339 | 09-07-2023 |
$10.78 | $10.775 | $10.78 | $10.78 | $10.775 | 431 | 09-06-2023 |
$10.8 | $10.85 | $10.8 | $10.85 | $10.8 | 998 | 09-05-2023 |
$10.9 | $10.6596 | $10.9 | $11.185 | $10.6596 | 20,511 | 09-04-2023 |
$10.9 | $10.6596 | $10.9 | $11.185 | $10.6596 | 20,511 | 09-01-2023 |
$10.681 | $10.5 | $10.681 | $10.94 | $10.5 | 176,213 | 08-31-2023 |
$10.6001 | $10.75 | $10.6001 | $10.75 | $10.6001 | 1,944 | 08-30-2023 |
$10.79 | $10.82 | $10.79 | $10.85 | $10.77 | 159,852 | 08-29-2023 |
$10.81 | $10.81 | $10.81 | $10.83 | $10.81 | 16,641 | 08-28-2023 |
News, Short Squeeze, Breakout and More Instantly...
Murphy Canyon Acquisition Corp. Company Name:
MURF Stock Symbol:
NASDAQ Market:
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the...
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited ("Conduit Pharmaceuticals"), a multi-asset clinical-stage disease-...
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose...